Table 1. Correlations of patient clinicopathologic characteristics with exosomal miR-665 expression level.
| Clinicopathological features | Exosomal miR-665 | P value | |||
|---|---|---|---|---|---|
| Low n(%) | High n(%) | ||||
| Sex | F | 18 | 8 (44.4) | 10 (55.6) | |
| M | 12 | 5 (41.7) | 7 (58.3) | P = 0.8804 | |
| Age | > 60 | 12 | 5 (41.7) | 7 (58.3) | |
| ≤ 60 | 18 | 8 (44.4) | 10 (55.6) | P = 0. 8804 | |
| HBsAg | + | 24 | 11 (45.8) | 13 (54.2) | |
| – | 6 | 2 (33.3) | 4 (66.7) | P = 0.5805 | |
| AFP (ng/mL) | > 20 | 22 | 10 (45.5) | 12 (54.5) | |
| ≤ 20 | 8 | 3 (37.5) | 5 (62.5) | P = 0.6974 | |
| Cirrhosis | + | 20 | 8 (40.0) | 12 (60.0) | |
| - | 10 | 5 (50.0) | 5 (50.0) | P = 0.6023 | |
| Tumour size (cm) | > 5 | 20 | 5 (25.0) | 15 (75.0) | |
| ≤ 5 | 10 | 8 (80.0) | 2 (20.0) | P = 0.0042 | |
| Capsule invasion | + | 9 | 1 (11.1) | 8 (88.9) | |
| – | 21 | 12 (57.1) | 9 (42.9) | P = 0.0197 | |
| TNM stage | III–IV | 24 | 8 (33.3) | 16 (66.7) | |
| I–II | 6 | 5 (83.3) | 1 (16.7) | P = 0.0276 | |